Publicaciones en las que colabora con BERTRAND MOREL (26)

2023

  1. Preparation and Investigation of Crucial Oligomers in the Early Stages of Aβ40 and Aβ42 Aggregation

    Methods in molecular biology (Clifton, N.J.), Vol. 2551, pp. 15-28

2021

  1. Conformational flexibility of the conserved hydrophobic pocket of HIV-1 gp41. Implications for the discovery of small-molecule fusion inhibitors

    International Journal of Biological Macromolecules, Vol. 192, pp. 90-99

  2. Extremely thermostabilizing core mutations in coiled‐coil mimetic proteins of hiv‐1 gp41 produce diverse effects on target binding but do not affect their inhibitory activity

    Biomolecules, Vol. 11, Núm. 4

  3. Rapid conversion of amyloid-beta 1-40 oligomers to mature fibrils through a self-catalytic bimolecular process

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

2020

  1. Molecular mechanisms of amyloid aggregation in human proteinopathies

    Protein Homeostasis Diseases: Mechanisms and Novel Therapies (Elsevier), pp. 153-179

  2. Probing Vulnerability of the gp41 C-Terminal Heptad Repeat as Target for Miniprotein HIV Inhibitors

    Journal of Molecular Biology, Vol. 432, Núm. 20, pp. 5577-5592

  3. Thermodynamic dissection of the interface between HIV-1 gp41 heptad repeats reveals cooperative interactions and allosteric effects

    Archives of Biochemistry and Biophysics, Vol. 688

2019

  1. Early mechanisms of amyloid fibril nucleation in model and disease-related proteins

    Biochimica et Biophysica Acta - Proteins and Proteomics, Vol. 1867, Núm. 11

  2. Structural and Thermodynamic Analysis of HIV-1 Fusion Inhibition Using Small gp41 Mimetic Proteins

    Journal of Molecular Biology, Vol. 431, Núm. 17, pp. 3091-3106

2018

  1. Dynamic micellar oligomers of amyloid beta peptides play a crucial role in their aggregation mechanisms

    Physical Chemistry Chemical Physics, Vol. 20, Núm. 31, pp. 20597-20614

  2. Global Protein Stabilization Does Not Suffice to Prevent Amyloid Fibril Formation

    ACS Chemical Biology, Vol. 13, Núm. 8, pp. 2094-2105

2017

  1. A mechanism for cancer-associated inactivation of NQO1 due to P187S and its reactivation by the consensus mutation H80R

    FEBS Letters, Vol. 591, Núm. 18, pp. 2826-2835

  2. The influence of N-terminal acetylation on micelle-induced conformational changes and aggregation of α-Synuclein

    PLoS ONE, Vol. 12, Núm. 5

2016

  1. Molecular and Physicochemical Factors Governing Solubility of the HIV gp41 Ectodomain

    Biophysical Journal, Vol. 111, Núm. 4, pp. 700-709

2015

  1. Molecular binding mechanism of TtgR repressor to antibiotics and antimicrobials

    PLoS ONE, Vol. 10, Núm. 9

  2. SH3 domains as suitable models to study amyloid aggregation

    SH Domains: Structure, Mechanisms and Applications (Springer International Publishing), pp. 1-15

2014

  1. Mapping the structure of amyloid nucleation precursors by protein engineering kinetic analysis

    Physical Chemistry Chemical Physics, Vol. 16, Núm. 7, pp. 2989-3000

  2. Single-chain protein mimetics of the N-terminal heptad-repeat region of gp41 with potential as anti-HIV-1 drugs

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 51, pp. 18207-18212

2013

  1. Modulation of the stability of amyloidogenic precursors by anion binding strongly influences the rate of amyloid nucleation

    Physical Chemistry Chemical Physics, Vol. 15, Núm. 37, pp. 15508-15517

2012

  1. Characterization of Oligomers of Heterogeneous Size as Precursors of Amyloid Fibril Nucleation of an SH3 Domain: An Experimental Kinetics Study

    PLoS ONE, Vol. 7, Núm. 11